In 1803 South Korean patients with AF at intermediate stroke risk (CHA2DS2-VASc 1 in men, 2 in women), DOACs vs no anticoagulation cut stroke, embolism, major bleeding or CV death at 24 months: 0.5% vs 1.5% (HR 0.31, 95% CI 0.10–0.94).
RCTn = 1,803
Kim et al. Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk